PNTG (Pennant Group) 3-Year RORE % : 14.42% (As of Mar. 2026)


PNTG Pennant Group Inc PNTG
89 GF Score
Price $39.93
GF Value $34.63
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Pennant Group 3-Year RORE %?

Pennant Group PNTG +3.61% 89 3-Year RORE % is 14.42 as of Mar. 2026. GuruFocus rates PNTG with a GF Score™ of 89/100 and a GF Value™ of $34.63 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Pennant Group ranks better than 65.12% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Pennant Group's 3-Year RORE % for the quarter that ended in Mar. 2026 was 14.42%.

The industry rank for Pennant Group's 3-Year RORE % or its related term are showing as below:

PNTG's 3-Year RORE % is ranked better than
65.12% of 605 companies
in the Healthcare Providers & Services industry
Industry Median: -0.32 vs PNTG: 14.42

Pennant Group  (NAS:PNTG) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Pennant Group 3-Year RORE % Related Terms


Pennant Group 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Pennant Group's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pennant Group 3-Year RORE % Chart

Pennant Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.85 -37.35 48.65 35.29 19.80

Pennant Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.90 19.02 17.84 19.80 14.42

PNTG vs AMN, NUTX, ARDT: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, Pennant Group's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pennant Group 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pennant Group's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Pennant Group's 3-Year RORE % falls into.


PNTG
89GF Score
Pennant Group Inc PNTG
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pennant Group 3-Year RORE % Calculation

Pennant Group's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.85-0.54 )/( 2.15-0 )
=0.31/2.15
=14.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of 14.42 mean?
Pennant Group (PNTG) has a 3-Year RORE % of 14.42 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Pennant Group and its competitors. According to the industry distribution chart, Pennant Group ranks #211 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 34.9%.
Is Pennant Group's 3-Year RORE % too high?
Pennant Group's current 3-Year RORE % is 14.42. Based on the distribution chart, Pennant Group ranks #211 out of 605 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Pennant Group has a GF Score™ of 89/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pennant Group's 3-Year RORE % compare to AMN and NUTX?
According to the Healthcare Providers & Services industry distribution chart, Pennant Group ranks #211 out of 605 companies for 3-Year RORE %. This puts Pennant Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
A good 3-Year RORE % depends on the Healthcare Providers & Services industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Pennant Group and its competitors. Pennant Group's current 3-Year RORE % is 14.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pennant Group stock overvalued right now?
Based on GuruFocus' analysis, Pennant Group (PNTG) is currently considered Modestly Overvalued. The stock's GF Value™ is $34.63, compared to a current price of $39.93 — trading 15.3% above its estimated fair value. The current 3-Year RORE % is 14.42. Pennant Group's overall GF Score™ is 89/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Pennant Group (PNTG), the current 3-Year RORE % is 14.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pennant Group (PNTG) Overvalued in 2026?

Based on GuruFocus' analysis, Pennant Group stock appears to be overvalued. The current stock price of $39.93 is trading 15.3% above its estimated GF Value™ of $34.63. GuruFocus considers Pennant Group to be Modestly Overvalued.

Key valuation signals for PNTG:

  • 3-Year RORE %: 14.42
  • GF Value™: $34.63 vs. price of $39.93 (15.3% above fair value)
  • GF Score™: 89/100 with 8 warning signs

No single metric tells the full story. See the PNTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pennant Group Business Description

Other Exchanges 1ZU:Germany
Address 1675 East Riverside Drive, Suite 150, Eagle, ID, USA, 83616
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
89GF Score

Get the complete analysis for PNTG

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$39.93
Price
$34.63
GF Value